مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
Normal view MARC view ISBD view

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. [electronic resource]

By:
  • Kelderman, Sander
Contributor(s):
  • Heemskerk, Bianca
  • van Tinteren, Harm
  • van den Brom, Rob R H
  • Hospers, Geke A P
  • van den Eertwegh, Alfonsus J M
  • Kapiteijn, Ellen W
  • de Groot, Jan Willem B
  • Soetekouw, Patricia
  • Jansen, Rob L
  • Fiets, Edward
  • Furness, Andrew J S
  • Renn, Alexandra
  • Krzystanek, Marcin
  • Szallasi, Zoltan
  • Lorigan, Paul
  • Gore, Martin E
  • Schumacher, Ton N M
  • Haanen, John B A G
  • Larkin, James M G
  • Blank, Christian U
Producer: 20140604Description: 449-58 p. digitalISSN:
  • 1432-0851
Subject(s):
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal -- therapeutic use
  • Biomarkers, Tumor -- analysis
  • Disease-Free Survival
  • Female
  • Humans
  • Ipilimumab
  • Kaplan-Meier Estimate
  • L-Lactate Dehydrogenase -- blood
  • Male
  • Melanoma -- drug therapy
  • Middle Aged
  • Skin Neoplasms -- drug therapy
  • Treatment Outcome
  • Young Adult
Online resources:
  • Available from publisher's website
In: Cancer immunology, immunotherapy : CII vol. 63
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Clinical Trial; Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.

APA

Kelderman S., Heemskerk B., van Tinteren H., van den Brom R. R. H., Hospers G. A. P., van den Eertwegh A. J. M., Kapiteijn E. W., de Groot J. W. B., Soetekouw P., Jansen R. L., Fiets E., Furness A. J. S., Renn A., Krzystanek M., Szallasi Z., Lorigan P., Gore M. E., Schumacher T. N. M., Haanen J. B. A. G., Larkin J. M. G. & Blank C. U. (20140604). Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. : Cancer immunology, immunotherapy : CII.

Chicago

Kelderman Sander, Heemskerk Bianca, van Tinteren Harm, van den Brom Rob R H, Hospers Geke A P, van den Eertwegh Alfonsus J M, Kapiteijn Ellen W, de Groot Jan Willem B, Soetekouw Patricia, Jansen Rob L, Fiets Edward, Furness Andrew J S, Renn Alexandra, Krzystanek Marcin, Szallasi Zoltan, Lorigan Paul, Gore Martin E, Schumacher Ton N M, Haanen John B A G, Larkin James M G and Blank Christian U. 20140604. Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. : Cancer immunology, immunotherapy : CII.

Harvard

Kelderman S., Heemskerk B., van Tinteren H., van den Brom R. R. H., Hospers G. A. P., van den Eertwegh A. J. M., Kapiteijn E. W., de Groot J. W. B., Soetekouw P., Jansen R. L., Fiets E., Furness A. J. S., Renn A., Krzystanek M., Szallasi Z., Lorigan P., Gore M. E., Schumacher T. N. M., Haanen J. B. A. G., Larkin J. M. G. and Blank C. U. (20140604). Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. : Cancer immunology, immunotherapy : CII.

MLA

Kelderman Sander, Heemskerk Bianca, van Tinteren Harm, van den Brom Rob R H, Hospers Geke A P, van den Eertwegh Alfonsus J M, Kapiteijn Ellen W, de Groot Jan Willem B, Soetekouw Patricia, Jansen Rob L, Fiets Edward, Furness Andrew J S, Renn Alexandra, Krzystanek Marcin, Szallasi Zoltan, Lorigan Paul, Gore Martin E, Schumacher Ton N M, Haanen John B A G, Larkin James M G and Blank Christian U. Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. : Cancer immunology, immunotherapy : CII. 20140604.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site